Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125919142 | 12591914 | 2 | F | 20160824 | 20160726 | 20160826 | EXP | PHJP2016JP020777 | NOVARTIS | 88.00 | YR | M | Y | 0.00000 | 20160826 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125919142 | 12591914 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4 DF, QD (4 PATCHES OF 1.9 MG (PATCH 2.5, 4.5 MG IN RIVASTIGMINE BASE) QD) | U | U | 22083 | 4 | DF | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125919142 | 12591914 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125919142 | 12591914 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125919142 | 12591914 | Drug administration error | |
| 125919142 | 12591914 | Infectious pleural effusion | |
| 125919142 | 12591914 | Pneumonia | |
| 125919142 | 12591914 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |